Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ELAVL1 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-10 |
mRNA | MYOF | CTRPv2 | pan-cancer | AAC | -0.23 | 6e-10 |
mRNA | IGFBP4 | CTRPv2 | pan-cancer | AAC | -0.2 | 8e-10 |
mRNA | MCM2 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-10 |
mRNA | SAFB | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
mRNA | SSRP1 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
mRNA | HNRNPK | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-09 |
mRNA | HEXA | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-09 |
mRNA | SNRNP40 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
mRNA | DAZAP1 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-09 |